RxDoctor Payments Data

Megan Lewis

Family · Hazard, KYNPI 1558814962

Payments from drug & device makers

$2,778in general payments, 2019–2025

Across 158 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$394
  • Johnson & Johnson$388
  • Novartis$352
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$300
  • AstraZeneca$232
  • E.r. Squibb & Sons, L.L.C.$184
  • plus $927 from 20 others

What the payments were for

  • Food & beverage$2,60494%
  • Education$1746%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,778 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban39$30,823
Repatha SureclickEvolocumab32$17,349
XareltoRivaroxaban15$10,300
BrilintaTicagrelor11$4,577
Metoprolol Succinate167$1,127
SotalolSotalol Hcl34$479
Valsartan39$460
Atorvastatin Calcium83$353
Nifedipine ErNifedipine38$353
Hydralazine Hcl40$321
ClopidogrelClopidogrel Bisulfate57$313
Amlodipine Besylate96$259
Lisinopril61$237
Losartan Potassium70$216
Metoprolol Tartrate81$182

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$394$30,82339 claims
Johnson & JohnsonXarelto$388$10,30015 claims
AstraZenecaBrilinta$232$4,57711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.

Other family in Hazard

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →